Shoulder Innovations, Inc. SI
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About SI
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
Shoulder Innovations, Inc. is a privately held medical technology company focused on orthopedic shoulder replacement systems and surgical technologies. The company operates within the broader musculoskeletal and orthopedic device industry, with a primary emphasis on shoulder arthroplasty implants designed for both anatomic and reverse shoulder replacement procedures. Its core revenue drivers are implant systems, related surgical instrumentation, and enabling technologies used by orthopedic surgeons and hospital systems. Publicly available information indicates the company markets differentiated implant designs intended to improve surgical efficiency, implant fixation, and procedural reproducibility in shoulder reconstruction.
The company was founded in Michigan and evolved from a surgeon-driven orthopedic innovation platform into a commercial-stage shoulder implant business serving orthopedic specialists and healthcare providers. Shoulder Innovations has positioned itself as a focused competitor within the shoulder arthroplasty segment rather than a diversified orthopedic manufacturer. Its strategic differentiation has centered on surgeon-centric implant design, streamlined instrumentation, and proprietary glenoid fixation technologies associated with its InSet™ platform. Data regarding detailed financial performance and market share is inconclusive based on available public sources because the company is privately held and does not publish comprehensive SEC reporting comparable to public issuers.
Business Operations
Shoulder Innovations generates revenue primarily through the sale of shoulder replacement implants, procedural instrumentation, and associated surgical technologies. Its principal commercial offerings include systems for reverse shoulder arthroplasty and anatomic shoulder reconstruction, including the InSet™ Shoulder System and related implant technologies. The company’s operations appear concentrated in orthopedic product development, surgeon education, regulatory compliance, and commercial distribution within the United States. Publicly available materials indicate that its products are used by orthopedic surgeons in hospitals and ambulatory surgical centers specializing in shoulder procedures.
Operationally, the company maintains a focused business structure rather than diversified operating segments typical of large multinational medtech firms. Shoulder Innovations has developed proprietary implant and fixation technologies intended to support minimally disruptive surgical workflows and implant stability. The company has also collaborated with orthopedic surgeons and medical institutions for product development and clinical adoption. Public disclosures indicate the business has received institutional investment support from healthcare-focused investment firms, though details regarding international distribution scale, manufacturing arrangements, and joint ventures remain limited in publicly available records.
Strategic Position & Investments
Shoulder Innovations’ strategic direction has focused on expanding adoption of its shoulder arthroplasty systems, increasing surgeon utilization, and broadening commercial reach in the orthopedic reconstruction market. The company has pursued growth through product innovation, surgeon training programs, and investment in next-generation implant technologies. Public announcements and investor materials indicate that Shoulder Innovations has completed multiple financing rounds intended to support commercialization, product development, and operational expansion.
The company operates in a specialized segment of orthopedic reconstruction that has experienced broader industry growth due to aging populations and increasing demand for shoulder replacement procedures. Shoulder Innovations has emphasized innovation in glenoid fixation and implant design as part of its competitive positioning against larger orthopedic companies. Available information also suggests continued investment in procedural efficiency technologies and surgeon workflow optimization. No verified public information confirms major acquisitions or large-scale subsidiary ownership comparable to diversified orthopedic conglomerates. Data regarding extensive portfolio company holdings or non-core investments is inconclusive based on available public sources.
Geographic Footprint
Shoulder Innovations is headquartered in Grand Rapids, Michigan, and its primary commercial presence has been concentrated in the United States orthopedic market. Publicly available information indicates the company markets its products to U.S.-based orthopedic surgeons, hospitals, and ambulatory surgical centers. The company operates within a healthcare ecosystem that includes surgeon training, medical education engagement, and distributor or sales network relationships supporting regional market penetration.
Although the company’s products may have exposure beyond the United States through limited distribution or regulatory initiatives, publicly verifiable information regarding a broad multinational operating footprint remains limited. There is insufficient publicly available evidence confirming extensive direct operations across Europe, Asia-Pacific, or Latin America comparable to major global orthopedic manufacturers. Data concerning large-scale international manufacturing infrastructure or foreign operating subsidiaries is inconclusive based on available public sources.
Leadership & Governance
Shoulder Innovations was founded with significant involvement from orthopedic surgeons and medical device industry professionals focused on shoulder reconstruction technologies. The company’s leadership approach has emphasized surgeon-informed product development, focused specialization within shoulder arthroplasty, and disciplined commercialization in the orthopedic device sector. Public company materials and industry announcements indicate management has prioritized innovation, clinical usability, and strategic growth supported by healthcare investors.
Key publicly identified executives and leadership figures include:
- Robert Ball – Chief Executive Officer
- Stephen Gunther, M.D. – Founder and orthopedic surgeon innovator
- Michael Gettings – Chief Financial Officer
- Eric Spangler – Chief Commercial Officer
Additional governance and board composition details are limited because the company is privately held and does not provide the same level of disclosure required of publicly traded corporations under standard SEC filings.